ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures
Retrieved on:
Thursday, December 10, 2020
The ADVANCE Women (Atraumatic Device using VAcuum Technology for CErvical Procedures in WOMEN) Phase I trial was conducted at Lausanne University Hospital (CHUV) by Prof. Patrice Mathevet, an expert in innovative gynecological surgical approaches, and his team.
Key Points:
- The ADVANCE Women (Atraumatic Device using VAcuum Technology for CErvical Procedures in WOMEN) Phase I trial was conducted at Lausanne University Hospital (CHUV) by Prof. Patrice Mathevet, an expert in innovative gynecological surgical approaches, and his team.
- The two-phase ADVANCE Women trial is assessing the usability, efficacy and safety of the investigational CAREVIX, an innovative, soft-suction cervical device designed as a modern and gentler alternative to a tenaculum to stabilize the cervix for the insertion of an Intrauterine Device (IUD) for contraception.
- "The innovative CAREVIX device is easy-to-use, and I am encouraged by its potential to enhance women's overall experience with an interest in IUD placement."
- ASPIVIX SA is a privately held medical device company based in Renens, Switzerland, dedicated to developing modern and gentle gynecological solutions that advance women's healthcare.